Second cancers following pediatric Hodgkin's disease

Journal of Clinical Oncology

Volumn 16, Issue 2, 1998, Pages 536-544

  Wolden, Suzanne L ^a   Lamborn, Kathleen R ^a   Cleary, Sean F ^a   Tate, David J ^a   Donaldson, Sarah S ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CHLORMETHINE; DACARBAZINE; DOXORUBICIN; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

AGE; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CHILD; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; LEUKEMIA; LUNG CANCER; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SECOND CANCER; SEX DIFFERENCE; SPLENECTOMY; TREATMENT OUTCOME;

EID: 0031941707     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.2.536     Document Type: Article

References (50)

1. DeVita VT, Canellos GP, Moxley JH: A decade of combination chemotherapy for advanced Hodgkin's disease. Cancer 30:1495-1504, 1972
2. Kaplan HS: Hodgkin's Disease (ed 2). Cambridge, MA, Harvard University Press, 1980
3. Bonadonna G: Chemotherapy strategies to improve the control of Hodgkin's disease. Cancer Res 42:4309-4320, 1982
4. Cleary SF, Link MP, Donaldson SS: Hodgkin's disease in the very young. Int J Radiat Oncol Biol Phys 28:77-83, 1994
5. Hunger SP, Link MP, Donaldson SS: ABVD/MOPP and low-dose involved-field radiotherapy in pediatric Hodgkin's disease: The Stanford experience. J Clin Oncol 12:2160-2166, 1994
6. Tarbell NJ, Gelber RD, Weinstein HJ, et al: Sex differences in risk of second malignant tumors after Hodgkin's disease in childhood. Lancet 341:1428-1432, 1993
7. Beaty O, Hudson MM, Greenwald C, et al: Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease. J Clin Oncol 13:603-609, 1995
8. Boivin JF: Second cancers and other late side effects of cancer treatment. Cancer 65:770-775, 1990
9. Green DM, Zevron MA, Reese PA, et al: Second malignant tumors following treatment during childhood and adolescence for cancer. Med Pediatr Oncol 22:1-10, 1994
10. Meadows AT: Risk factors for second malignant neoplasms: Report from the Late Effects Study Group. Bull Cancer 75:125-130, 1988
11. Meadows AT, Obringer AC, Marrero O, et al: Second malignant neoplasms following childhood Hodgkin's disease: Treatment and splenectomy as risk factors. Med Pediatr Oncol 17:477-484, 1989
12. Kushner BN, Zauber A, Tan CT: Second malignancies after childhood Hodgkin's disease. Cancer 62:1364-1370, 1988
13. Bhatia S, Robison LL, Oberlin O, et al: Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 334:745-751, 1996
14. Boivin JF, Hutchison GB, Zauber AG, et al: Incidence of second cancers in patients treated for Hodgkin's disease. J Natl Cancer Inst 87:732-741, 1995
15. Sankila R, Garwicz S, Olsen JH, et al: Risk of subsequent malignant neoplasms among 1641 Hodgkin's disease patients diagnosed in childhood and adolescence: A population-based cohort study in the five Nordic countries. J Clin Oncol 14:1442-1446, 1996
16. Jenkin D, Greenberg M, Fitzgerald A: Second malignant tumors in childhood Hodgkin's disease. Med Pediatr Oncol 26:373-379, 1996
17. Lavey RS, Eby NL, Prosnitz LR: Impact on second malignancy risk of the combined use of radiation and chemotherapy for lymphomas. Cancer 66:80-88, 1990
18. Holm LE: Cancer occurring after radiotherapy and chemotherapy. Im J Radiat Oncol Biol Phys 19:1303-1308, 1990
19. Urba WJ, Longo DL: Hodgkin's disease. N Engl J Med 326:678-687, 1992
20. Robison LL, Mertens A: Second tumors after treatment of childhood malignancies. Hematol Oncol Clin North Am 7:401-415, 1993
21. Kaldor JM, Day NE, Clarke EA, et al: Leukemia following Hodgkin's disease. N Engl J Med 322:7-13, 1990
22. van Leeuwen FE, Klokman WJ, Hagenbeek A, et al: Second cancer risk following Hodgkin's disease: A 20-year follow-up study. J Clin Oncol 12:312-325, 1994
23. Abrahamsen JF, Andersen A, Hannisdal E, et al: Second malignancies after treatment of Hodgkin's disease: The influence of treatment, follow-up time, and age. J Clin Oncol 11:255-261, 1993
24. Curtis RE, Boice JD: Second cancer after radiotherapy for Hodgkin's disease. N Engl J Med 319:244-245, 1988
25. Hancock SL, Tucker MA, Hoppe RT: Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst 85:25-31, 1993
26. Tucker MA, D'Angio GJ, Boice JD, et al: Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med 317:588-593, 1987
27. Tucker MA, Morris-Jones PH, Boice JD, et al: Therapeutic radiation at a young age is linked to secondary thyroid cancer. Cancer Res 51:2885-2888, 1991
28. Tucker MA, Coleman CN, Cox RS, et al: Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med 318:76-81, 1988
29. Com B, Curtis MT, Lynch D, et al: Malignant oligodendroglioma arising after radiation therapy for lymphoma. Med Pediatr Oncol 22:45-52, 1994
30. Robison LL: Survivors of childhood cancer and the risk of second tumor. J Natl Cancer Inst 85:1102-1103, 1993
31. MacMahon B: Epidemiological evidence on the nature of Hodgkin's disease. Cancer 10:1045-1054, 1957
32. Le Floch O, Donaldson SS, Kaplan HS: Pregnancy following oophoropexy and total nodal irradiation in women with Hodgkin's disease. Cancer 38:2263-2268, 1976
33. Schultz HP, Glatstein E, Kaplan HS: Management of presumptive or proven Hodgkin's disease of the liver; A new radiotherapy technique. Int J Radiat Oncol Biol Phys 1:1-8, 1975
34. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. Am Stat Assoc 53:457-481, 1958
35. Armitage P, Berry G: Statistical Methods in Medical Research (ed 3). Oxford, United Kingdom, Blackwell Scientific, 1994, pp 498-491
36. Breslow NE, Day NE: Statistical Methods in Cancer Research, vol 2: The Design and Analysis of Cohort Studies. London, United Kingdom, Oxford University Press, pp 65-70, 131, 1987
37. Cox DR: Regression models and life-tables. J R Stat Soc B 334:187-202, 1972
38. Horning SJ, Ang PT, Hoppe RT, et al: The Stanford experience with combined procarbazine, Alkeran, and vinblastine (PAVe) and radiotherapy for locally extensive and advanced stage Hodgkin's disease. Ann Oncol 3:747-754, 1992
39. Palos B, Kaplan HS, Karzmark CJ: The use of thin lung shields to deliver limited whole-lung irradiation during mantle-field treatment of Hodgkin's disease. Radiology 101:441-442, 1971
40. Salloum E, Doria R, Schubert W, et al: Second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation. J Clin Oncol 14:2435-2443, 1996
41. Boivin JF, O'Brien K: Solid cancer risk after treatment of Hodgkin's disease. Cancer 61:2541-2546, 1988
42. Tucker MA: Solid second cancers following Hodgkin's disease. Hematol Oncol Clin North Am 7:389-400, 1993
43. Miller AB, Howe GR, Sherman GJ, et al: Mortality from breast cancer after irradiation during fluoroscopic examinations in patients being treated for tuberculosis. N Engl J Med 321:1285-1289, 1989
44. Tokunga M, Land CE, Yamamoto T, et al: Incidence of female breast cancer among atomic bomb survivors. Hiroshima and Nagasaki, 1950-1980. Radiat Res 112:243-272, 1987
45. Lundell M, Mattsson A, Hakulinen T, et al: Breast cancer after radiotherapy for skin hemangioma in infancy. Radiat Res 145:225-230, 1996
46. Boice JD, Harvey EB, Blettner M, et al: Cancer in the contralateral breast after radiotherapy for breast cancer. N Engl J Med 326:781-785, 1992
47. Tucker MA, Misfeldt D, Coleman CN, et al: Cutaneous malignant melanoma after Hodgkin's disease. Ann Intern Med 102:37-41, 1985
48. Slivnick D, Nawrocki J, Fisher R: Immunology and cellular biology of Hodgkin's disease. Hematol Oncol Clin North Am 3:205-220, 1989
49. Fuks Z, Strober S, Bobrove AM, et al: Long term effects of radiation on T and B lymphocytes in peripheral blood of patients with Hodgkin's disease. J Clin Invest 58:803-814, 1976
50. Wolden SL, Carlson RW, Jeffrey SS, et al: Management of breast cancer following Hodgkin's disease. Int J Radiat Oncol Biol Phys 39:258, 1997 (abstr)